ADMA/SDMA

This panel measures Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)—two key markers of vascular health, nitric oxide metabolism, and kidney function. ADMA reflects endothelial dysfunction and impaired nitric oxide production (linked to blood pressure, inflammation, and aging), while SDMA is a sensitive indicator of kidney filtration efficiency. Together, they provide early insight into cardiovascular risk, renal stress, and metabolic resilience, often before more common markers show problems.

Health impacts

Heart Health